Showing results (21-30 of 44) with videos related to
Sort By:
Pageof 5
Harm Reduction Journal|September 4, 2019
Geographic distribution of risk ("Hotspots") for HIV, HCV, and drug overdose among persons who use drugs in New York City: the importance of local historyD C Des Jarlais, C McKnight, K Arasteh, et al.Plos One|March 30, 2018
Potential geographic "hotspots" for drug-injection related transmission of HIV and HCV and for initiation into injecting drug use in New York City, 2011-2015, with implications for the current opioid epidemic in the USD C Des Jarlais, H L F Cooper, K Arasteh, et al.Infection|June 9, 2005
Treatment of HIV-1-associated Kaposi's sarcoma with pegylated liposomal doxorubicin and HAART simultaneously induces effective tumor remission and CD4+ T cell recoveryM Lichterfeld, N Qurishi, C Hoffmann, et al.AIDS and Behavior|November 26, 2013
Combined HIV prevention, the New York City condom distribution program, and the evolution of safer sex behavior among persons who inject drugs in New York CityD C Des Jarlais, K Arasteh, C McKnight, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study GroupS Stewart, H Jablonowski, F D Goebel, et al.Journal of Clinical Microbiology|November 1, 1995
Intestinal cytomegalovirus disease in immunocompromised patients may be ruled out by search for cytomegalovirus DNA in stool samplesD Michel, E Marre, W Hampl, et al.Deutsche Medizinische Wochenschrift (1946)|October 5, 1990
[Intestinal spirochetosis in HIV infection: prevalence, isolation and morphology of spirochetes]A Käsbohrer, H R Gelderblom, K Arasteh, et al.Zeitschrift Fur Gastroenterologie|December 1, 1989
[Gastrointestinal cytomegalovirus manifestations in AIDS]W Heise, P Mostertz, K Arasteh, et al.HIV Medicine|December 12, 2001
Intensification of stable background therapy with abacavir in antiretroviral therapy experienced patients: 48-week data from a randomized, double-blind trialC Katlama, B Clotet, A Plettenberg, et al.Medizinische Klinik (Munich, Germany : 1983)|April 1, 1990
[Comparison of the effect of 2 therapy concepts in the treatment of Pneumocystis carinii pneumonia. Cotrimoxazole for 21 days versus sequential therapy with cotrimoxazole followed by pentamidine inhalation]E B Helm, S Staszewski, K Arasteh, et al.Pageof 5